Contributed by guest blogger: Stephanie Mischell ’12 Herpes simplex virus type 1 (HSV-1) is making news due to a paper by Jing et al identifying two promising new candidate antigens for a vaccine. HSV-1 is a widespread public health issue, infecting approximately 60% of Americans and causing symptoms, most likely cold sores or genital sores … Continue reading After many setbacks, cross-presentation provides new hope for a Herpes Simplex Virus 1 vaccine